Table of Contents Author Guidelines Submit a Manuscript
Abstract and Applied Analysis
Volume 2015, Article ID 850670, 15 pages
http://dx.doi.org/10.1155/2015/850670
Research Article

A Computational Study of HSV-2 with Poor Treatment Adherence

Department of Mathematics, University of Zimbabwe, P.O. Box MP 167, Mount Pleasant, Harare, Zimbabwe

Received 3 July 2015; Revised 31 August 2015; Accepted 25 October 2015

Academic Editor: Yanni Xiao

Copyright © 2015 A. Mhlanga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Laga, M. O. Diallo, and A. Buvé, “Interrelationship of sexually transmitted diseases and HIV: where are we now?” AIDS, vol. 8, no. 1, pp. S119–S124, 1994. View at Google Scholar · View at Scopus
  2. S. O. Aral and J. N. Wasserheit, “STD-related health care seeking and health service delivery,” in Sexually Transmitted Diseases, K. K. Holmes, P. F. Sparling, P. A. Mardh et al., Eds., pp. 1295–1306, McGraw-Hill, New York, NY, USA, 3rd edition, 1999. View at Google Scholar
  3. S. Kalichman and D. Rompa, “HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy,” Sexually Transmitted Infections, vol. 79, no. 1, pp. 59–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Mushayabasa and C. P. Bhunu, “Modeling the impact of early therapy for latent tuberculosis patients and its optimal control analysis,” The Journal of Biological Physics, vol. 39, no. 4, pp. 723–747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Christensen, Patience Adherence to Medical Treatment Regimens: Bridging the Gap between Behavioral Science and Biomedicine, Yale University Press, New Haven, Conn, USA, 2004.
  6. P. J. McDonnell and M. R. Jacobs, “Hospital admissions resulting from preventable adverse drug reactions,” Annals of Pharmacotherapy, vol. 36, no. 9, pp. 1331–1336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. B. L. Senst, L. E. Achusim, R. P. Genest et al., “Practical approach to determining costs and frequency of adverse drug events in a health care network,” American Journal of Health-System Pharmacy, vol. 58, no. 12, pp. 1126–1132, 2001. View at Google Scholar · View at Scopus
  8. D. Watson-Jones, H. A. Weiss, M. Rusizoka et al., “Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: peparing for an HSV-2 intervention trial,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, no. 5, pp. 631–642, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Feng, Z. Qiu, Z. Sang, C. Lorenzo, and J. Glasser, “Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy,” Mathematical Biosciences, vol. 245, no. 2, pp. 171–187, 2013. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  10. A. P. Fiddian, A. M. Halsos, B. R. Kinge, A. E. Nilsen, and K. Wikstrom, “Oral acyclovir in the treatment of genital herpes. Preliminary report of a multicenter trial,” The American Journal of Medicine, vol. 73, no. 1, pp. 335–337, 1982. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Celum, R. Levine, M. Weaver, and A. Wald, “Genital herpes and human immunodeficiency virus: double trouble,” Bulletin of the World Health Organization, vol. 82, no. 6, pp. 447–453, 2004. View at Google Scholar · View at Scopus
  12. H. B. Bosworth, Improving Patient Treatment Adherence. A Clinician's Guide, Springer, New York, NY, USA, 2010. View at Publisher · View at Google Scholar
  13. M. L. Plummer, D. Watson-Jones, S. Lees et al., “A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania,” AIDS Care: Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 22, no. 4, pp. 499–508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Blower, T. C. Porco, and G. Darby, “Predicting and preventing the emergence of antiviral drug resistance in HSV-2,” Nature Medicine, vol. 4, no. 6, pp. 673–678, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Mhlanga, C. P. Bhunu, and S. Mushayabasa, “HSV-2 and substance abuse amongst adolescents: insights through mathematical modelling,” Journal of Applied Mathematics, vol. 2014, Article ID 104819, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. N. Podder and A. B. Gumel, “Transmission dynamics of a two-sex model for herpes simplex virus type-2,” Canadian Applied Mathematics Quarterly, vol. 7, no. 2, pp. 339–386, 2009. View at Google Scholar · View at MathSciNet
  17. S. Blower and P. Volberding, “What can modeling tell us about the threat of antiviral drug resistance?” Current Opinion in Infectious Diseases, vol. 15, no. 6, pp. 609–614, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Foss, P. T. Vickerman, Z. Chalabi, P. Mayaud, M. Alary, and C. H. Watts, “Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty,” Bulletin of Mathematical Biology, vol. 71, no. 3, pp. 720–749, 2009. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  19. L. J. Abu-Raddad, A. S. Magaret, C. Celum et al., “Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa,” PLoS ONE, vol. 3, no. 5, Article ID e2230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. R. Bangsberg, S. Perry, E. D. Charlebois et al., “Non-adherence to highly active antiretroviral therapy predicts progression to AIDS,” AIDS, vol. 15, no. 9, pp. 1181–1183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. E. Golin, H. Liu, R. D. Hays et al., “A prospective study of predictors of adherence to combination antiretroviral medication,” Journal of General Internal Medicine, vol. 17, no. 10, pp. 756–765, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Van den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,” Mathematical Biosciences, vol. 180, no. 1-2, pp. 29–48, 2002. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  23. R. A. Horn and C. R. Johnson, Matrix Analysis, Cambridge University Press, Cambridge, UK, 1985. View at Publisher · View at Google Scholar · View at MathSciNet
  24. H. L. Smith and P. Waltman, The Theory of the Chemostat, Cambridge University Press, 1995. View at Publisher · View at Google Scholar · View at MathSciNet
  25. H. R. Thieme, “Persistence under relaxed point-dissipativity (with application to an endemic model),” SIAM Journal on Mathematical Analysis, vol. 24, no. 2, pp. 407–435, 1993. View at Publisher · View at Google Scholar · View at MathSciNet
  26. J. Li, Y. Yang, and Y. Zhou, “Global stability of an epidemic model with latent stage and vaccination,” Nonlinear Analysis: Real World Applications, vol. 12, no. 4, pp. 2163–2173, 2011. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  27. H.-F. Huo and R. Chen, “Stability of an HIV/AIDS treatment model with different stages,” Discrete Dynamics in Nature and Society, vol. 2015, Article ID 630503, 9 pages, 2015. View at Publisher · View at Google Scholar · View at MathSciNet
  28. D. R. Powell, J. Fair, R. J. Le Claire, L. M. Moore, and D. Thompson, “Sensitivity analysis of an infectious disease model,” in Proceedings of the International System Dynamics Conference, Boston, Mass, USA, July 2005.
  29. L. M. Arriola and J. M. Hyman, “Being sensitive to uncertainty,” Computing in Science and Engineering, vol. 9, no. 2, pp. 10–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Wright, Y. Htun, M. G. Leong, P. Forman, and R. C. Ballard, “Evaluation of the use of calendar blister packaging on patient compliance with STD syndromic treatment regimens,” Sexually Transmitted Diseases, vol. 26, no. 10, pp. 556–563, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Beaucage, H. Lachance-Demers, T. T.-T. Ngo et al., “Telephone follow-up of patients receiving antibiotic prescriptions from community pharmacies,” American Journal of Health-System Pharmacy, vol. 63, no. 6, pp. 557–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Reyes, H. Guiscafre, O. Muñoz, R. Perez-Cuevas, H. Martinez, and G. Gutierrez, “Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea,” Journal of Clinical Epidemiology, vol. 50, no. 11, pp. 1297–1304, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Kardas, “Patient compliance with antibiotic treatment for respiratory tract infections,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 6, pp. 897–903, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. H. R. Joshi, “Optimal control of an HIV immunology model,” Optimal control applications and methods, vol. 23, no. 4, pp. 199–213, 2002. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  35. D. Kirschner, S. Lenhart, and S. Serbin, “Optimal control of the chemotherapy of HIV,” Journal of Mathematical Biology, vol. 35, no. 7, pp. 775–792, 1997. View at Publisher · View at Google Scholar · View at MathSciNet
  36. L. S. Pontryagin, V. T. Boltyanskii, R. V. Gamkrelidze, and E. F. Mishchevko, The Mathematical Theory of Optimal Processes, vol. 4, Gordon and Breach Science Publishers, 1985.
  37. W. H. Fleming and R. W. Rishel, Deterministic and Stochastic Optimal Control, Springer, New York, NY, USA, 1975. View at MathSciNet
  38. M. Reitano, S. Tyring, W. Lang et al., “Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study,” Journal of Infectious Diseases, vol. 178, no. 3, pp. 603–610, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Watson-Jones, K. Baisley, M. Rusizoka et al., “Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania,” Contemporary Clinical Trials, vol. 30, no. 6, pp. 504–512, 2009. View at Publisher · View at Google Scholar · View at Scopus